Specifically, among the 15,264 females on GLP-1 drugs, 1.62% were diagnosed with breast cancer during the study, compared to 2.47% of the 96,382 females who did not use GLP-1 medications
We stratified patients by the peak dosage of the medication prescribed within the year of GLP-1 treatment to determine how dosage might influence the amount of weight loss experienced
Importantly, experts caution that GLP-1 drugs are not yet approved for neurodegenerative diseases, and further large-scale trials are needed to confirm efficacy
In fact, CJC 1295 has been shown to be effective in releasing growth hormone sufficiently and can increase muscle mass, fatty acid metabolism, and recovery accordingly when used adequately
10.1016/j.dsx.2020.03.008 11
This specific localization within the GCL is of profound clinical relevance, as retinal ganglion cells are the primary neurons that degenerate in glaucoma and are also critically affected during the early neurodegenerative stages of diabetic retinopathy [38, 39]
